Publications by authors named "Randi Foster"

Claim this Profile
A
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade.
John O DaSilva, Katie Yang, Oliver Surriga, Thomas Nittoli, Arthur Kunz, Randi Foster

Mol Cancer Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5.
Adrianna Latuszek, Yashu Liu, Olav Olsen, Randi Foster, Marc Cao

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.
Janelle C Waite, Bei Wang, Lauric Haber, Aynur Hermann, Erica Ullman, Randi Foster

Sci Transl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes.
Srijata Sarkar, Junfeng Han, Kristina S Sinsimer, Baisong Liao, Randi L Foster

Mol Cell Biol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AUF1 isoform-specific regulation of anti-inflammatory IL10 expression in monocytes.
Srijata Sarkar, Kristina S Sinsimer, Randi L Foster, Gary Brewer, Sidney Pestka

J Interferon Cytokine Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Pamela Krueger, Christina Nitz, Randi Foster, Colleen MacDonald, Oren Gelber

Cancer Immunol Immunother· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis